Bullying Prevention Intervention for Adolescent Primary Care Patients
NCT ID: NCT03467009
Last Updated: 2019-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
77 participants
INTERVENTIONAL
2018-03-06
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention Media to Prevent Adolescent Cyber-conflict Through Technology
NCT04259216
BullyDown, a Text Messaging-based Bullying Prevention Program for Middle School-aged Youth
NCT06017050
Electronic Pre-visit Questionnaire to Prompt Discussions of Youth Violence in Primary Care
NCT02041182
Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents
NCT03626103
Coaching Teachers in Bullying Detection and Intervention
NCT05321342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Almost 80% of adolescents have a well-child visit with their pediatrician each year. Pediatricians recognize this visit as an important opportunity for behavioral screening, interventions, and referrals, but they currently lack cyber-victimization interventions that are feasible and effective in the clinical setting. Personalized text-message interventions are accessible, feasible, and may be effective with these adolescents.
The purpose of this study is to test the feasibility and acceptability of a novel text-message-augmented secondary prevention intervention, "iPACT." Drawing on effective cognitive behavioral therapy (CBT) and motivational interviewing (MI) depression and violence prevention interventions, a brief in-clinic session will introduce basic cognitive and behavioral strategies. Following their clinic visit, eight weeks of tailored CBT-informed daily text messages will be sent, to enhance skills and remind participants of self-determined goals.
Participants will be identified in the course of usual clinical care. If eligible, parents will be consented and participants assented. Participants will complete a baseline assessment and will be randomized to experimental (iPACT, n=25) or enhanced usual care (EUC, n=25) care, using stratified block randomization.
iPACT group participants will participate in a brief, structured in-clinic introduction on CBT and the iPACT program, followed by 8 weeks of tailored, two-way, CBT-and MI-informed automated text messages (short message service, SMS). EUC group participants will receive standardized information on cyberbullying. The current standard of care for these patients is no care: no cyber-victimization screening assessment protocols are currently used in our clinic. Both iPACT and EUC conditions therefore exceed current levels of care.
At baseline, 8 week follow-up, and 16 week follow-up, participants will complete assessments on cyberbullying, peer violence, and cognitive/behavioral skill-sets. At the 8-week follow-up, standardized qualitative and quantitative process measures will be administered to assess efficacy, acceptability, usability, and feasibility.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
iPACT Intervention
1. In-clinic brief session, introducing basic principles of cognitive behavioral theory and the structure of the text-message portion of the intervention.
2. Eight-week longitudinal tailored CBT-based text-message program.
iPACT Intervention
Brief in-person + tailored, daily 8-week text-message secondary prevention intervention.
Control: Enhanced Usual Care (EUC)
The investigators will provide participants with a standard resource sheet with information on bullying and mental health resources.
Control: Enhanced Usual Care (EUC)
EUC group participants will receive standardized information on cyberbullying.
iPACT Intervention- App
1. In-clinic brief session, introducing basic principles of cognitive behavioral theory and the structure of the message portion of the intervention delivered via app.
2. Eight-week longitudinal tailored CBT-based message program delivered via app.
iPACT Intervention- app
Brief in-person + tailored, daily 8-week message secondary prevention intervention delivered via app.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iPACT Intervention
Brief in-person + tailored, daily 8-week text-message secondary prevention intervention.
Control: Enhanced Usual Care (EUC)
EUC group participants will receive standardized information on cyberbullying.
iPACT Intervention- app
Brief in-person + tailored, daily 8-week message secondary prevention intervention delivered via app.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* being mentally and physically able to assent
* being English-speaking
* having a consentable parent present
* self-reporting cyber-victimization (defined as endorsing \>1 past-year episode of technology-mediated victimization)
Exclusion Criteria
* suspected by clinical staff of being a victim of child abuse
* currently incarcerated or under police custody
13 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Rhode Island Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Megan L Ranney, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Rhode Island Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rhode Island Hospital
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.